Yahoo Web Search

Search results

    • Why Iovance Stock Is Down 18% Today

      Why Iovance Stock Is Down 18% Today

      Motley Fool via Yahoo Finance· 4 days ago

      They reflect sales of Proleukin, which Iovance acquired in early 2023. This drug improves the response to some immunotherapies, including Amtagvi....